Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventral Tegmental Area | 10 | 2021 | 74 | 3.690 |
Why?
|
| Habenula | 9 | 2020 | 13 | 3.290 |
Why?
|
| Neural Pathways | 15 | 2020 | 323 | 2.820 |
Why?
|
| Tegmentum Mesencephali | 6 | 2021 | 52 | 2.510 |
Why?
|
| Reward | 13 | 2022 | 201 | 2.480 |
Why?
|
| Neurons | 22 | 2021 | 881 | 2.360 |
Why?
|
| Avoidance Learning | 5 | 2021 | 58 | 2.340 |
Why?
|
| Dopamine | 9 | 2021 | 474 | 2.260 |
Why?
|
| Behavior, Animal | 11 | 2021 | 470 | 1.760 |
Why?
|
| Cocaine | 8 | 2022 | 555 | 1.450 |
Why?
|
| Cocaine-Related Disorders | 4 | 2021 | 504 | 1.260 |
Why?
|
| Punishment | 2 | 2019 | 25 | 1.250 |
Why?
|
| Protein Precursors | 6 | 2020 | 105 | 1.220 |
Why?
|
| Rats, Sprague-Dawley | 23 | 2021 | 2083 | 1.210 |
Why?
|
| Receptors, Opioid | 6 | 2020 | 60 | 1.190 |
Why?
|
| Mesencephalon | 3 | 2019 | 41 | 1.180 |
Why?
|
| Conditioning, Operant | 5 | 2019 | 241 | 1.080 |
Why?
|
| Rats | 29 | 2022 | 5300 | 0.970 |
Why?
|
| Action Potentials | 7 | 2019 | 223 | 0.970 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2019 | 208 | 0.900 |
Why?
|
| Animals | 45 | 2022 | 20880 | 0.890 |
Why?
|
| Dopaminergic Neurons | 2 | 2021 | 46 | 0.830 |
Why?
|
| Behavior | 1 | 2021 | 59 | 0.770 |
Why?
|
| Entopeduncular Nucleus | 1 | 2020 | 1 | 0.760 |
Why?
|
| Drug-Seeking Behavior | 3 | 2021 | 213 | 0.760 |
Why?
|
| Substantia Nigra | 2 | 2012 | 102 | 0.730 |
Why?
|
| Basal Forebrain | 1 | 2020 | 15 | 0.710 |
Why?
|
| Globus Pallidus | 1 | 2019 | 64 | 0.650 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 94 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-fos | 8 | 2020 | 114 | 0.630 |
Why?
|
| Repressor Proteins | 2 | 2018 | 182 | 0.620 |
Why?
|
| Learning | 1 | 2019 | 186 | 0.600 |
Why?
|
| Motivation | 5 | 2020 | 561 | 0.570 |
Why?
|
| Receptors, Opioid, mu | 3 | 2012 | 70 | 0.500 |
Why?
|
| Nerve Net | 2 | 2016 | 180 | 0.490 |
Why?
|
| Circadian Rhythm | 7 | 2015 | 218 | 0.490 |
Why?
|
| Motor Activity | 5 | 2018 | 621 | 0.450 |
Why?
|
| Male | 31 | 2021 | 37283 | 0.450 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 498 | 0.450 |
Why?
|
| Pedunculopontine Tegmental Nucleus | 2 | 2011 | 2 | 0.440 |
Why?
|
| Periaqueductal Gray | 3 | 2019 | 9 | 0.420 |
Why?
|
| Oligopeptides | 2 | 2012 | 152 | 0.410 |
Why?
|
| Sleep | 8 | 2008 | 263 | 0.400 |
Why?
|
| Corpus Striatum | 1 | 2012 | 278 | 0.370 |
Why?
|
| Feeding Behavior | 5 | 2022 | 224 | 0.340 |
Why?
|
| Neuropeptides | 4 | 2004 | 106 | 0.320 |
Why?
|
| Afferent Pathways | 3 | 2009 | 31 | 0.300 |
Why?
|
| Neurotransmitter Agents | 2 | 2008 | 102 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2004 | 216 | 0.290 |
Why?
|
| Suprachiasmatic Nucleus | 4 | 2015 | 7 | 0.290 |
Why?
|
| Synaptic Transmission | 3 | 2021 | 236 | 0.280 |
Why?
|
| Hypothalamic Area, Lateral | 3 | 2004 | 17 | 0.270 |
Why?
|
| Limbic System | 1 | 2006 | 106 | 0.270 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2005 | 10 | 0.270 |
Why?
|
| Wakefulness | 6 | 2008 | 75 | 0.260 |
Why?
|
| Preoptic Area | 4 | 2008 | 19 | 0.260 |
Why?
|
| Behavior, Addictive | 2 | 2022 | 317 | 0.260 |
Why?
|
| Self Administration | 5 | 2020 | 419 | 0.260 |
Why?
|
| Amygdala | 2 | 2020 | 159 | 0.230 |
Why?
|
| Rats, Wistar | 3 | 2013 | 371 | 0.220 |
Why?
|
| Cues | 3 | 2020 | 654 | 0.220 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 1033 | 0.210 |
Why?
|
| Parvalbumins | 1 | 2022 | 29 | 0.210 |
Why?
|
| Food Addiction | 1 | 2022 | 3 | 0.210 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 1242 | 0.210 |
Why?
|
| Choice Behavior | 2 | 2016 | 85 | 0.200 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 2 | 2019 | 3 | 0.200 |
Why?
|
| Fear | 2 | 2019 | 239 | 0.200 |
Why?
|
| Ethanol | 2 | 2019 | 892 | 0.190 |
Why?
|
| Individuality | 1 | 2021 | 44 | 0.190 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 20 | 0.190 |
Why?
|
| Nucleus Accumbens | 3 | 2021 | 417 | 0.180 |
Why?
|
| Neurons, Afferent | 1 | 2019 | 32 | 0.170 |
Why?
|
| Opioid Peptides | 1 | 2019 | 17 | 0.170 |
Why?
|
| Glutamate Decarboxylase | 2 | 2009 | 18 | 0.170 |
Why?
|
| Glutamic Acid | 2 | 2020 | 332 | 0.170 |
Why?
|
| Central Amygdaloid Nucleus | 1 | 2019 | 16 | 0.170 |
Why?
|
| Antipsychotic Agents | 1 | 2021 | 247 | 0.170 |
Why?
|
| Optogenetics | 1 | 2018 | 20 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2001 | 597 | 0.150 |
Why?
|
| Hypothalamic Hormones | 2 | 2004 | 13 | 0.150 |
Why?
|
| Pituitary Hormones | 2 | 2004 | 16 | 0.150 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2019 | 13 | 0.150 |
Why?
|
| Muscimol | 2 | 2019 | 26 | 0.150 |
Why?
|
| Melanins | 2 | 2004 | 24 | 0.150 |
Why?
|
| Rats, Transgenic | 1 | 2016 | 24 | 0.140 |
Why?
|
| Hypothalamus | 3 | 2008 | 78 | 0.140 |
Why?
|
| Taste | 1 | 2016 | 49 | 0.140 |
Why?
|
| Biotin | 2 | 2015 | 28 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2009 | 1663 | 0.130 |
Why?
|
| Anxiety | 1 | 2019 | 422 | 0.130 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 99 | 0.130 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2019 | 435 | 0.130 |
Why?
|
| Stilbamidines | 2 | 2003 | 13 | 0.130 |
Why?
|
| Ibotenic Acid | 2 | 2003 | 9 | 0.130 |
Why?
|
| Acetylcholinesterase | 1 | 2004 | 19 | 0.120 |
Why?
|
| Efferent Pathways | 1 | 2014 | 15 | 0.120 |
Why?
|
| Histamine | 1 | 2004 | 52 | 0.120 |
Why?
|
| Neural Inhibition | 2 | 2011 | 80 | 0.120 |
Why?
|
| Models, Economic | 1 | 2014 | 69 | 0.120 |
Why?
|
| Dynorphins | 2 | 2008 | 69 | 0.120 |
Why?
|
| Body Temperature | 2 | 2001 | 116 | 0.120 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 1 | 2003 | 2 | 0.120 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2015 | 266 | 0.120 |
Why?
|
| Rats, Long-Evans | 3 | 2019 | 203 | 0.110 |
Why?
|
| Obesity | 2 | 2022 | 1074 | 0.110 |
Why?
|
| Philosophy | 1 | 2002 | 4 | 0.110 |
Why?
|
| Presynaptic Terminals | 1 | 2003 | 34 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 215 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1293 | 0.110 |
Why?
|
| Cognition | 1 | 2016 | 512 | 0.110 |
Why?
|
| Oxytocin | 1 | 2014 | 124 | 0.110 |
Why?
|
| Raphe Nuclei | 1 | 2012 | 10 | 0.110 |
Why?
|
| Neuronal Plasticity | 1 | 2015 | 274 | 0.110 |
Why?
|
| Organophosphonates | 1 | 2012 | 16 | 0.110 |
Why?
|
| Time Factors | 2 | 2018 | 4655 | 0.100 |
Why?
|
| Pons | 1 | 2012 | 35 | 0.100 |
Why?
|
| Adenosine | 1 | 2003 | 165 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2008 | 1174 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 514 | 0.100 |
Why?
|
| Cell Count | 4 | 2004 | 248 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2012 | 78 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 128 | 0.100 |
Why?
|
| Rod Opsins | 1 | 2001 | 59 | 0.100 |
Why?
|
| Hypothalamus, Anterior | 1 | 2001 | 2 | 0.100 |
Why?
|
| Activity Cycles | 1 | 2001 | 5 | 0.100 |
Why?
|
| Arousal | 3 | 2020 | 168 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2001 | 72 | 0.100 |
Why?
|
| Homeostasis | 1 | 2002 | 291 | 0.100 |
Why?
|
| Methamphetamine | 2 | 2009 | 132 | 0.090 |
Why?
|
| Mice | 5 | 2022 | 8474 | 0.090 |
Why?
|
| Cholera Toxin | 3 | 2015 | 30 | 0.090 |
Why?
|
| Sulfur Radioisotopes | 1 | 2009 | 11 | 0.090 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2009 | 3 | 0.080 |
Why?
|
| Somatostatin | 1 | 2009 | 36 | 0.080 |
Why?
|
| Electroshock | 1 | 2009 | 36 | 0.080 |
Why?
|
| Appetitive Behavior | 1 | 2009 | 18 | 0.080 |
Why?
|
| Humans | 8 | 2022 | 68549 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 2 | 2019 | 204 | 0.080 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 57 | 0.080 |
Why?
|
| Maze Learning | 1 | 2009 | 138 | 0.080 |
Why?
|
| Pain | 1 | 2012 | 472 | 0.080 |
Why?
|
| Orexins | 3 | 2004 | 52 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1745 | 0.080 |
Why?
|
| Photic Stimulation | 3 | 2012 | 229 | 0.070 |
Why?
|
| Gene Expression | 1 | 2009 | 770 | 0.070 |
Why?
|
| Goals | 1 | 2006 | 65 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2006 | 180 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 2791 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2015 | 200 | 0.060 |
Why?
|
| Dextrans | 2 | 2015 | 33 | 0.060 |
Why?
|
| Electroencephalography | 3 | 2008 | 418 | 0.060 |
Why?
|
| Sucrose | 1 | 2022 | 58 | 0.050 |
Why?
|
| Darkness | 2 | 2003 | 27 | 0.050 |
Why?
|
| Microinjections | 2 | 2003 | 130 | 0.050 |
Why?
|
| Appetite | 1 | 2022 | 16 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2015 | 531 | 0.050 |
Why?
|
| Food | 1 | 2022 | 52 | 0.050 |
Why?
|
| Fornix, Brain | 2 | 2001 | 5 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2003 | 191 | 0.050 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2021 | 87 | 0.050 |
Why?
|
| Prefrontal Cortex | 1 | 2006 | 639 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 100 | 0.050 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2021 | 109 | 0.050 |
Why?
|
| Light | 2 | 2012 | 152 | 0.050 |
Why?
|
| Electromyography | 2 | 2001 | 184 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2008 | 201 | 0.040 |
Why?
|
| Self Stimulation | 1 | 2019 | 6 | 0.040 |
Why?
|
| Parabrachial Nucleus | 1 | 2019 | 1 | 0.040 |
Why?
|
| Solitary Nucleus | 1 | 2019 | 3 | 0.040 |
Why?
|
| Septal Nuclei | 1 | 2019 | 31 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 81 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2020 | 240 | 0.040 |
Why?
|
| Calcium | 1 | 2022 | 929 | 0.040 |
Why?
|
| Adiposity | 1 | 2019 | 88 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 554 | 0.040 |
Why?
|
| Saccharin | 1 | 2016 | 4 | 0.040 |
Why?
|
| Lithium Chloride | 1 | 2016 | 10 | 0.040 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2015 | 19 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2016 | 136 | 0.030 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2015 | 32 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 81 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 2004 | 6 | 0.030 |
Why?
|
| Hypothalamus, Posterior | 1 | 2004 | 6 | 0.030 |
Why?
|
| Neurons, Efferent | 1 | 2014 | 1 | 0.030 |
Why?
|
| Neuronal Tract-Tracers | 1 | 2014 | 2 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2014 | 5 | 0.030 |
Why?
|
| Tomography | 1 | 2014 | 9 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 65 | 0.030 |
Why?
|
| Dependovirus | 1 | 2014 | 34 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 70 | 0.030 |
Why?
|
| Amphetamine | 1 | 2014 | 77 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 282 | 0.030 |
Why?
|
| Neurotoxins | 1 | 2003 | 30 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 438 | 0.030 |
Why?
|
| Melatonin | 1 | 2003 | 39 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2014 | 311 | 0.030 |
Why?
|
| Galanin | 1 | 2003 | 3 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2003 | 122 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2012 | 47 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 333 | 0.030 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 2002 | 3 | 0.030 |
Why?
|
| Axonal Transport | 1 | 2002 | 9 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2003 | 186 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 2002 | 16 | 0.030 |
Why?
|
| Silver Staining | 1 | 2002 | 11 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 221 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2002 | 30 | 0.030 |
Why?
|
| Biogenic Monoamines | 1 | 2002 | 18 | 0.030 |
Why?
|
| Light Signal Transduction | 1 | 2001 | 6 | 0.030 |
Why?
|
| Vision, Ocular | 1 | 2012 | 68 | 0.030 |
Why?
|
| Ataxin-3 | 1 | 2001 | 4 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2003 | 396 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2001 | 15 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 120 | 0.020 |
Why?
|
| Brain | 2 | 2002 | 2176 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 32 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2011 | 76 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2001 | 98 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2001 | 93 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 689 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2001 | 81 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2001 | 240 | 0.020 |
Why?
|
| Female | 3 | 2019 | 38021 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 213 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 271 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 290 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 455 | 0.020 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2008 | 37 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2001 | 753 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2001 | 1692 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2008 | 184 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2550 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 2689 | 0.010 |
Why?
|